首页> 外文OA文献 >Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies

【2h】

Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies

机译：PD-1 / PD-L1抑制剂在老年人和脆弱患者的安全性和耐受性，晚期恶性肿瘤患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tomoki Sakakida; Takeshi Ishikawa; Junji Uchino; Yusuke Tabuchi; Satoshi Komori; Jun Asai; Akihito Arai; Hiroaki Tsunezuka; Toshiyuki Kosuga; Hirotaka Konishi; Fumiya Hongo; Masayoshi Inoue; Shigeru Hirano; Osamu Ukimura; Tetsuya Taguchi; Koichi Takayama; Yoshito Itoh;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis [J] . Nishijima Tomohiro F., Shachar Shlomit S., Nyrop Kirsten A., The oncologist . 2017,第4期

机译：PD-1 / PD-L1抑制剂的安全性和耐受性与晚期癌症患者的化疗相比：META分析
2. Effectivity and safety of PD-1/PD-L1 inhibitors for different level of PD-L1-positive, advanced NSCLC: A meta-analysis of 4939 patients from randomized controlled trials [J] . International immunopharmacology . 2020,第期

机译：PD-1 / Pd-L1抑制剂对不同水平PD-L1阳性，高级NSCLC的影响和安全性：4939例随机对照试验的荟萃分析
3. Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer [J] . Baraibar Iosune, Melero Ignacio, Ponz-Sarvise Mariano, Drug safety: An international journal of medical toxicology and drug experience . 2019,第2期

机译：免疫检查点抑制剂（PD-1和PD-L1）在癌症中的安全性和耐受性
4. Multiparametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues [C] . Shawn P. Fahl International Molecular Medicine Tri-Conference. . 2019

机译：离聚肿瘤和正常组织中检查点抑制剂（PD-1和PD-L1）的多次流式细胞术分析
5. The safety and tolerability of regadenoson in patients with end stage renal disease. [D] . Rangel, Maria Octavia. 2013

机译：regadenoson在晚期肾病患者中的安全性和耐受性。
6. Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials [O] . Xiang Li, Shi Yan, Jichun Yang, 2020

机译：PD-1 / PD-L1抑制剂的疗效和安全性PL和PD-1 / PD-L1抑制剂在先进的非小细胞肺癌中：随机对照试验的网络分析
7. Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma [O] . Liting Zhong, Dehua Wu, Weiwei Peng, 2021

机译：PD-1 / PD-L1抑制剂的安全性与高级肝细胞癌中的姑息放疗和抗血管生成治疗联合

Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅